Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3024% above fair value
$32.41+0.31 (+0.97%)
Close on Nov 17, 2026Market cap $1.39BP/E 40.0Yield 1.17%
Cadre operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cadre's operating cash flow for the twelve months ending Jun 30, 2026 was $88.38M, up 129.7% year over year. For fiscal 2025 it was $63.71M, up 100.5% from the year before. The highest annual figure on record is $73.21M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.71M | +100.5% |
| FY2024 | Dec 31, 2024 | $31.78M | -56.6% |
| FY2023 | Dec 31, 2023 | $73.21M | +57.7% |
| FY2022 | Dec 31, 2022 | $46.41M | +15.8% |
| FY2021 | Dec 31, 2021 | $40.09M | -11.7% |
| FY2020 | Dec 31, 2020 | $45.42M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.13M | +755.1% |
| Q1 FY2026 | Mar 31, 2026 | $22.52M | +29.5% |
| Q4 FY2025 | Dec 31, 2025 | $21.25M | -10.4% |
| Q3 FY2025 | Sep 30, 2025 | $22.48M | – |
| Q2 FY2025 | Jun 30, 2025 | $2.59M | -76.8% |
| Q1 FY2025 | Mar 31, 2025 | $17.39M | +713.8% |
| Q4 FY2024 | Dec 31, 2024 | $23.71M | -12.0% |
| Q3 FY2024 | Sep 30, 2024 | -$5.21M | -129.0% |
| Q2 FY2024 | Jun 30, 2024 | $11.14M | -28.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.14M | -83.2% |
| Q4 FY2023 | Dec 31, 2023 | $26.95M | +59.4% |
| Q3 FY2023 | Sep 30, 2023 | $17.99M | +301.3% |
| Q2 FY2023 | Jun 30, 2023 | $15.55M | -3.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.72M | +42.7% |
| Q4 FY2022 | Dec 31, 2022 | $16.91M | +85.7% |
| Q3 FY2022 | Sep 30, 2022 | $4.48M | +96.5% |
| Q2 FY2022 | Jun 30, 2022 | $16.10M | +35.6% |
| Q1 FY2022 | Mar 31, 2022 | $8.92M | -47.0% |
| Q4 FY2021 | Dec 31, 2021 | $9.11M | -47.1% |
| Q3 FY2021 | Sep 30, 2021 | $2.28M | – |
| Q2 FY2021 | Jun 30, 2021 | $11.88M | – |
| Q1 FY2021 | Mar 31, 2021 | $16.83M | – |
| Q4 FY2020 | Dec 31, 2020 | $17.23M | – |
See a number that looks wrong?